Roche gets closed R&D site prepped for sale; Cipla and Teva team up in South Africa; Chinese heparin maker gets warning letter;

> Roche ($RHHBY) officials say soil and groundwater remediation is going well at its former R&D site in Nutley, NJ, that it is prepping for sale. Story

> Cipla's Medpro Pharmaceuticals subsidiary has struck a deal to distribute drugs for Teva Pharmaceutical Industries ($TEVA) in South Africa. Report

> The Nigerian government has invested about $600 million to get prequalification from the World Health Organization for four drug manufacturers. Report

> Roquette has expanded its excipients and active ingredients services at its site in Lestrem, France. Report

And Finally… The FDA has told heparin maker Beijing Shunxin Meihua Bio-technical in China that its drugs will be considered adulterated because it refused to allow inspectors into the facility. Warning Letter